A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act

Chimonas S. Rozario N. M. Rothman D. J. , “Show Us the Money: Lessons in Transparency from State Pharmaceutical Marketing Disclosure Laws,” HSR 45, no. 1 (2010): 98–114, at 99;.

Lo B. , “Commentary: Conflict of Interest Policies: An Opportunity for the Medical Profession to Take the Lead,” Academic Medicine 85, no. 1 (2010): 9–11.

Steinbrook R. Ross J. S. , “Transparency Reports on Industry Payments to Physicians and Teaching Hospitals,” JAMA 307, no. 10 (2012): 1029–1030.

Centers for Medicare and Medicaid Services, “Medicare, Medicaid, Children's Health Insurance Programs: Transparency Reports and Reporting of Physician Ownership or Investment Interests,” Federal Register 78, no. 27 (2013): 9458–9528, at 9458–9459.

Berland G. K. Elliott M. N. Morales L. S. Algazy J. I. Kravitz R. L. Broder M. S. , “Health Information on the Internet: Accessibility, Quality and Readability in English and Spanish,” JAMA 285, no. 20 (2001): 2612–2621, at 2612–2613.

See Centers for Medicare and Medicaid Services, supra note 3, at 9475;.

Kim P. Eng T. R. Deering M. J. Maxfield A. , “Published Criteria for Evaluating Health Related Web Sites: Review,” BMJ 318, no. 7184 (1999): 647–649.

See Centers for Medicare and Medicaid Services, supra note 3, at 9459.

Executive Office of Health and Human Services, State of Massachusetts, “Frequently Asked Questions, Pharmaceutical and Medical Device Manufacturer Code of Conduct,” last modified March 29, 2012, available at <http://www.mass.gov/eohhs/docs/dph/quality/healthcare/pharm-medical-device-conduct-faq.pdf>(last visited April 17, 2014).

“Lilly Physician Payment Registry,” available at <http://206.246.145.152/>(last visited April 17, 2014).

“Merck Ethics and Transparency,” available at <http://www.merckresponsibility.com/focus-areas/ethics-transparency/transparency-disclosures/payments-to-u-s-based-healthcare-professionals/>(last visited April 23, 2014).

Cephalon , “Relationships with Healthcare Professionals,” available at <http://www.cephalon.com/our-responsibility/relationships-with-healthcare-professionals.html>(last visited October 22, 2012). N.B. Cephalon has since been acquired by Teva Pharmaceuticals. The above link is no longer active. Teva Pharmaceuticals USA offers a new link at <http://www.tevausa.com/Relationships.aspx>(last visited April 23, 2014).

Medtronic, “Physician Registry,” available at <http://www.medtronic.com/about-medtronic/physician-collaboration/physican-registry/index.htm>(last visited April 17, 2014).

Stryker , “Meet Our Consultants,” available at <http://www.stryker.com/meetourconsultants/consultants/consultants.php>(last visited April 17, 2014).

Pfizer , “Pfizer's Disclosure of Payments to HCPs Frequently Asked Questions,” available at <http://www.pfizer.com/responsibility/working_with_hcp/faqs_hcp.jsp>(last visited April 17, 2014).

DePuy Synthes, “Physician and Institution Pymt,” available at <http://www.depuy.com/about-depuy/depuy-divisions/depuy-orthopaedics/find-surgeon>(last accessed October 22, 2012).

Pfizer , “Pfizer's Disclosure of Payments to HCPs Frequently Asked Questions,” available at <http://www.pfizer.com/responsibility/working_with_hcp/faqs_hcp.jsp#Q12>(last visited April 17, 2014).

Glaxosmithkline, “Glaxosmithkline Frequently Asked Questions,” available at <http://us.gsk.com/html/responsibility/speakers-advisors-faqs.html#11>(last accessed October 22, 2012). N.B. In December 2013, GSK announced that it will stop paying U.S. health care professionals outside of the company to speak. The above link is no longer active and has been replaced by <http://fortherecord.payments.us.gsk.com/transparency.html>(last visited April 23, 2014).

Donelan K. Rogers R. S. Eisenhauer A. Mort E. Agnihotri A. K. , “Consumer Comprehension of Surgeon Performance Data for Coronary Bypass Procedures,” Annals of Thoracic Surgery 91, no. 5 (2011): 1400–1406.

See Centers for Medicare and Medicaid Services, supra note 3, at 9481.

Id, at 9474.

Rodwin M. A. , “Physicians' Conflicts of Interest: The Limitations of Disclosure,” New England Journal of Medicine 321, no. 20 (1989): 1405–1408, at 1405.

See Centers for Medicare and Medicaid Services, supra note 3, at 9503.

Rosenthal M. B. Mello M. M. , “Sunlight as Disinfectant –New Rules on Disclosure of Industry Payments to Physicians,” New England Journal of Medicine 368, no. 22 (2013): 2052–2054, at 2053.

See Center for Medicare and Medicaid Services, supra note 3, at 9503–9504.

Brennan T. A. Rothman D. J. Blank L. Blumenthal D. Chimonas S. C. Cohen J. J. , “Health Industry Practices That Create Conflicts of Interest,” JAMA 295, no. 4 (2006): 429–433;.

IOM (Institute of Medicine), Lo B. Field M. J. , eds., Conflict of Interest in Medical Research, Education, and Practice (Washington, D.C.: The National Academies Press, 2009): At Ch. 6–7.

Wazana A. , “Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?” JAMA 283, no. 3 (2000): 373–380.

See Lo Field , supra note 19;.

Association of American Medical Colleges (AAMC), In the Interest of Patients: Recommendations of Physician Financial Relationships and Clinical Decision Making (Washington, D.C.: AAMC, 2010).

See Centers for Medicare and Medicaid Services, supra note 3, at 9459.

MMIS, Inc., “Sunshine Act: More Than 50% of Physicians Unprepared,” MMIS Media Center, February 4, 2013, available at <http://www.mmis-inc.com/pressrelease_3rdphysiciansurvey>(last visited April 17, 2014).

Agrawal S. Brennan N. Budetti P. , “The Sunshine Act – Effects on Physicians,” New England Journal of Medicine 368, no. 22 (2013): 2054–2057.

Licurse A. Barber E. Joffe S. Gross C. , “The Impact of Disclosing Financial Ties in Research and Clinical Care,” Archives of Internal Medicine 170, no. 8 (2010): 675–682.

Cain D. M. Loewenstein G. Moore D. A. , “When Sunlight Fails to Disinfect: Understanding the Perverse Effects of Disclosing Conflicts of Interest,” Journal of Consumer Research 37, no. 5 (2011): 836–857;.

Loewenstein G. Sah S. Cain D. M. , “The Unintended Consequences of Conflict of Interest Disclosure,” JAMA 307, no. 7 (2012): 669–670;.

Hampson L. A. Agrawal M. Joffe S. Gross C. P. Verter J. Emanuel E. J. , “Patients' Views on Financial Conflicts of Interest in Cancer Research Trials,” New England Journal of Medicine 355, no. 22 (2006): 2330–2337;.

Weinfurt K. P. Hall M. A. King N. M. P. Friedman J. Y. Schulman K. A. Sugarman J. , “Disclosure of Financial Relationship to Participants in Clinical Research,” New England Journal of Medicine 361, no. 9 (2009): 916–921.

Pham-Kanter G. Alexander G. C. Nair K. , “Effect of Physician Payment Disclosure Laws on Prescribing,” Archives of Internal Medicine 172, no. 10 (2012): 819–821.